![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SP3 |
Gene summary for SP3 |
![]() |
Gene information | Species | Human | Gene symbol | SP3 | Gene ID | 6670 |
Gene name | Sp3 transcription factor | |
Gene Alias | SPR2 | |
Cytomap | 2q31.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q02447 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6670 | SP3 | CA_HPV_1 | Human | Cervix | CC | 2.09e-03 | -1.60e-02 | 0.0264 |
6670 | SP3 | CCI_2 | Human | Cervix | CC | 7.96e-04 | 6.47e-01 | 0.5249 |
6670 | SP3 | CCI_3 | Human | Cervix | CC | 2.34e-05 | 7.28e-01 | 0.516 |
6670 | SP3 | L1 | Human | Cervix | CC | 7.06e-03 | -2.04e-01 | 0.0802 |
6670 | SP3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.03e-19 | -5.86e-01 | 0.0155 |
6670 | SP3 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.75e-04 | -4.03e-01 | -0.1808 |
6670 | SP3 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.90e-05 | -5.17e-01 | -0.1207 |
6670 | SP3 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.11e-02 | -4.10e-01 | -0.1526 |
6670 | SP3 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.24e-09 | -4.25e-01 | -0.1464 |
6670 | SP3 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.17e-06 | -3.82e-01 | -0.1001 |
6670 | SP3 | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.88e-03 | -3.87e-01 | -0.059 |
6670 | SP3 | HTA11_866_3004761011 | Human | Colorectum | AD | 4.34e-07 | -4.37e-01 | 0.096 |
6670 | SP3 | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.42e-02 | -5.36e-01 | 0.0528 |
6670 | SP3 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.53e-02 | -3.91e-01 | 0.0338 |
6670 | SP3 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.91e-11 | -4.57e-01 | 0.0674 |
6670 | SP3 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.80e-05 | -3.84e-01 | 0.294 |
6670 | SP3 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.30e-06 | -3.96e-01 | 0.3859 |
6670 | SP3 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.49e-02 | -4.78e-01 | 0.2585 |
6670 | SP3 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.48e-10 | -4.56e-01 | 0.3005 |
6670 | SP3 | F007 | Human | Colorectum | FAP | 3.30e-02 | -1.64e-01 | 0.1176 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0002262113 | Thyroid | PTC | myeloid cell homeostasis | 79/5968 | 157/18723 | 1.11e-06 | 1.64e-05 | 79 |
GO:0051100113 | Thyroid | PTC | negative regulation of binding | 81/5968 | 162/18723 | 1.14e-06 | 1.67e-05 | 81 |
GO:003017719 | Thyroid | PTC | positive regulation of Wnt signaling pathway | 72/5968 | 140/18723 | 1.16e-06 | 1.69e-05 | 72 |
GO:0034329111 | Thyroid | PTC | cell junction assembly | 180/5968 | 420/18723 | 1.17e-06 | 1.69e-05 | 180 |
GO:000183817 | Thyroid | PTC | embryonic epithelial tube formation | 64/5968 | 121/18723 | 1.27e-06 | 1.83e-05 | 64 |
GO:000716020 | Thyroid | PTC | cell-matrix adhesion | 109/5968 | 233/18723 | 1.28e-06 | 1.84e-05 | 109 |
GO:0070849111 | Thyroid | PTC | response to epidermal growth factor | 32/5968 | 49/18723 | 1.56e-06 | 2.19e-05 | 32 |
GO:005160420 | Thyroid | PTC | protein maturation | 132/5968 | 294/18723 | 1.71e-06 | 2.39e-05 | 132 |
GO:00457867 | Thyroid | PTC | negative regulation of cell cycle | 166/5968 | 385/18723 | 1.93e-06 | 2.64e-05 | 166 |
GO:001402016 | Thyroid | PTC | primary neural tube formation | 52/5968 | 94/18723 | 2.14e-06 | 2.89e-05 | 52 |
GO:0030218113 | Thyroid | PTC | erythrocyte differentiation | 63/5968 | 120/18723 | 2.14e-06 | 2.89e-05 | 63 |
GO:000740918 | Thyroid | PTC | axonogenesis | 178/5968 | 418/18723 | 2.17e-06 | 2.91e-05 | 178 |
GO:002191514 | Thyroid | PTC | neural tube development | 76/5968 | 152/18723 | 2.40e-06 | 3.17e-05 | 76 |
GO:000110119 | Thyroid | PTC | response to acid chemical | 69/5968 | 135/18723 | 2.55e-06 | 3.34e-05 | 69 |
GO:0031098111 | Thyroid | PTC | stress-activated protein kinase signaling cascade | 113/5968 | 247/18723 | 3.16e-06 | 4.10e-05 | 113 |
GO:000184310 | Thyroid | PTC | neural tube closure | 49/5968 | 88/18723 | 3.24e-06 | 4.20e-05 | 49 |
GO:00606069 | Thyroid | PTC | tube closure | 49/5968 | 89/18723 | 4.99e-06 | 6.08e-05 | 49 |
GO:003514819 | Thyroid | PTC | tube formation | 73/5968 | 148/18723 | 7.04e-06 | 8.31e-05 | 73 |
GO:0048511111 | Thyroid | PTC | rhythmic process | 131/5968 | 298/18723 | 7.06e-06 | 8.33e-05 | 131 |
GO:0071364111 | Thyroid | PTC | cellular response to epidermal growth factor stimulus | 29/5968 | 45/18723 | 7.13e-06 | 8.38e-05 | 29 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SP3 | SNV | Missense_Mutation | c.1030N>A | p.Asp344Asn | p.D344N | Q02447 | protein_coding | tolerated(0.18) | benign(0.011) | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SP3 | SNV | Missense_Mutation | c.2128N>T | p.His710Tyr | p.H710Y | Q02447 | protein_coding | tolerated(0.82) | possibly_damaging(0.579) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD | |
SP3 | SNV | Missense_Mutation | c.518T>G | p.Ile173Arg | p.I173R | Q02447 | protein_coding | deleterious(0) | probably_damaging(0.956) | TCGA-B6-A0I9-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
SP3 | SNV | Missense_Mutation | c.2066N>A | p.Arg689His | p.R689H | Q02447 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-D8-A142-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamid | SD | |
SP3 | SNV | Missense_Mutation | novel | c.1996G>T | p.Asp666Tyr | p.D666Y | Q02447 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-E9-A245-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
SP3 | insertion | Frame_Shift_Ins | novel | c.1023_1024insTT | p.Thr342LeufsTer3 | p.T342Lfs*3 | Q02447 | protein_coding | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
SP3 | SNV | Missense_Mutation | novel | c.2324C>T | p.Ser775Phe | p.S775F | Q02447 | protein_coding | deleterious(0.01) | probably_damaging(0.915) | TCGA-C5-A1MN-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
SP3 | SNV | Missense_Mutation | rs761430393 | c.2165N>T | p.Ala722Val | p.A722V | Q02447 | protein_coding | tolerated(0.26) | benign(0) | TCGA-LP-A4AU-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
SP3 | SNV | Missense_Mutation | novel | c.1985T>G | p.Phe662Cys | p.F662C | Q02447 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SP3 | SNV | Missense_Mutation | novel | c.706N>T | p.Val236Phe | p.V236F | Q02447 | protein_coding | deleterious(0) | benign(0.383) | TCGA-AA-A01K-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6670 | SP3 | TRANSCRIPTION FACTOR | DOXORUBICIN | DOXORUBICIN | 17511886 |
Page: 1 |